Viromed Medical AG (Q11) — Financial Flexibility Index
Viromed Medical AG (Q11) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of €10.10 Million (operating CF €-10.12 Million minus capex €20.22 Million) represents 0% of total liabilities (€69.84 Million). Check Viromed Medical AG strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Viromed Medical AG Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Viromed Medical AG across 4 annual periods. See working capital to net assets of Viromed Medical AG to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Viromed Medical AG (2021–2024)
Year-by-year free cash flow to debt coverage for Viromed Medical AG. For the full company profile including market capitalisation, see Viromed Medical AG market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.92x | €105.40 Million | €-6.03 Million | €54.82 Million | ▲ +938.3% |
| 2023 | -0.23x | €-9.85 Million | €-34.16 Million | €42.96 Million | ▲ +97.9% |
| 2022 | -11.00x | €-20.55 Million | €-20.87 Million | €1.87 Million | ▼ -197.1% |
| 2021 | -3.70x | €-10.41 Million | €-22.29 Million | €2.81 Million | — |